Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-frequency rTMS plus sertraline for post-stroke depression
TCTR20180112001Phase 3Completed
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by Faculty of Medicine, Chulalongkorn University. Started Apr 2014; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20180112001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180112001.